• Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join A Project
    • All Projects
    • Chemical Safety Library Project
    • DataFAIRy Bioassay Annotation Project
    • Diversity & Inclusion in STEM Leadership Program
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Microbiome Project
    • Natural Language Processing Use Case Database Project
    • Semantic Enrichment of ELN Data Project
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Clinical Trial Environmental Impact
    • Controlled Substance Compliance
    • Lab of the Future
    • Pistoia Alliance/FDA In Vitro Pharmacology
    • Quantum Computing
    • Social Media & Real-World Evidence
    • User Experience for Life Sciences
  • Submit an Idea
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
    • Global Knowledge-Sharing Events
    • Past Webinars
  • News

  • Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join A Project
    • All Projects
    • Chemical Safety Library Project
    • DataFAIRy Bioassay Annotation Project
    • Diversity & Inclusion in STEM Leadership Program
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Microbiome Project
    • Natural Language Processing Use Case Database Project
    • Semantic Enrichment of ELN Data Project
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Clinical Trial Environmental Impact
    • Controlled Substance Compliance
    • Lab of the Future
    • Pistoia Alliance/FDA In Vitro Pharmacology
    • Quantum Computing
    • Social Media & Real-World Evidence
    • User Experience for Life Sciences
  • Submit an Idea
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
    • Global Knowledge-Sharing Events
    • Past Webinars
  • News
Become a Member
Search

Search...

  • Menu

PRESS RELEASE

Pistoia Alliance and FDA Collaborate to Establish In Vitro Pharmacology Working Group to Accelerate Regulatory Submissions

FDA will participate in Pistoia Alliance’s working group as it develops a standardized and shared data template for pre-clinical pharmacology data submissions

Boston, US, September 13, 2022: The Pistoia Alliance a global not-for-profit that advocates for greater collaboration in life sciences R&D, has today announced the creation of a new In Vitro Pharmacology Working Group. The group will include liaisons from the US Food and Drug Administration’s Center for Drug Evaluation and Research, as well as representatives from biopharmaceutical companies, contract research organizations (CROs), technology suppliers, and regulatory agencies. The mission of the group is to improve the data structures and standards for in vitro pharmacology (IVP) data in regulatory submissions, to enable faster reviews and interpretations of submissions, and ensure new therapies reach patients as quickly as possible.

 

The working group will create a shared data structure based on FAIR principles to ensure data consistency in IVP screening across all stakeholders. Companies carry out extensive IVP screening throughout the drug discovery process to support Investigational New Drug Applications (IND) that are submitted to the FDA, which then assesses the drug candidate’s safety before a candidate moves to the next stage of development and into clinical testing. The current lack of consistent standards around data input, reporting, and submission is a common challenge that causes significant inconsistencies in regulatory submissions and limits the accessibility and interoperability of the data.

 

“The aim of everyone involved in the drug development ecosystem is to get the most safe and efficacious therapies to patients in the shortest possible time. By working collaboratively, biopharmaceutical companies, CROs, technology suppliers, and regulatory agencies can accelerate the timeline by standardizing how IVP data is reported. Working together also reduces the cost and time burden of individually developing solutions to a shared problem,” commented Veronique Francois, Project Manager, Pistoia Alliance. “The Alliance’s experience in bringing together experts to solve common challenges, alongside our formal framework for collaboration, empowers members to cooperate on initiatives that are driving change at the highest levels. We are keen to hear from both members and non-members interested in contributing to this collaborative community of interest and encourage them to get in touch.”

 

The data template that the IVP working group develops will include detailed and standardized descriptions of in vitro methodologies used for investigational drug safety characterization, alongside a repository of annotated in vitro assay methods. The data structure will utilize new or existing ontologies for the description of common assays to provide greater consistency in regulatory submissions. By employing a common standard, data outputs will also be computer readable. This safeguards the provenance of data and provides a secure audit trail, as well as enabling more effective data analysis to support better decision-making.

 

The Pistoia Alliance is calling on members and non-members– including biopharmaceutical companies, CROs, technology and solution providers, and electronic laboratory notebook (ELN) developers – who are interested in contributing to help establish new standards to get involved. Any interested party should contact the Pistoia Alliance via: ProjectInquiries@PistoiaAlliance.org.

 

—END—

 

About the Pistoia Alliance
The Pistoia Alliance is a global, not-for-profit members’ organization made up of life science companies, technology, and service providers, publishers, and academic groups working to lower barriers to innovation in life science and healthcare R&D. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis, and Pfizer who met at a conference in Pistoia, Italy. Its projects transform R&D through pre-competitive collaboration. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots. There are currently over 200 member companies; members collaborate on projects that generate significant value for the worldwide life sciences R&D community, using The Pistoia Alliance’s proven framework for open innovation.

 

Media Contact:
Spark Communications
+44 207 436 0420
pistoiaalliance@sparkcomms.co.uk

 

Tanya Randall
Communication & Public Relations Lead, Pistoia Alliance
+44 7887 811332
tanya.randall@pistoiaalliance.org

Join our Mailing List

Posted on September 13, 2022 by Yasheaka Oakley
Categories: Pharmacology, Pistoia Alliance News

Tags: collaboration, FDA, in vitro, innovation, pharmacology, Pistoia, pistoia alliance


Events

15 Feb 2023

Get to Know the Pistoia Alliance and our Projects

Book this event >
22 Feb 2023 - 23 Feb 2023

SmartLab Exchange

Book this event >
09 Mar 2023 - 10 Mar 2023

Lab of the Future USA Congress

Boston United States
Book this event >
15 Mar 2023

Collaborate to Innovate: Pistoia Alliance Japan Conference

Book this event >
Follow Us
Active Projects
Natural Language Processing (NLP) Use Case Database Project
IDMP Ontology Project
Diversity & Inclusion in STEM Leadership Program
Unified Integrated Knowledge Base
Microbiome Project
Data Visualization Project
Methods Hub Project
Informed Consent Blockchain Project
Quality Generation and Ethical Use of Digital Health Data in Clinical Studies
Semantic Enrichment of ELN Data Project (SEED)
Sign up for Pistoia Alliance Communications

© Copyright Pistoia Alliance, Inc., 2020 | Contact us at info@pistoiaalliance.org | Terms of use | Privacy Statement

By clicking "Agree" you are agreeing to the following terms and conditions for the use of the UDM XML Schema definition.

This website intends to use cookies to improve the site and provide you with a better browsing experience. If you select "Continue" or continue to browse the site without customizing your choices, you agree to our use of cookies. Find out more in our Online Privacy Statement.

Continue More Info